You are here

580b57fcd9996e24bc43c53e   LinkedIn Logo 500x500   Facebook logo square   Iguana Trans cropped

event icon
Date
17.06.21
Start time
20:00
End time
21:00
Online (Zoom)
Yorkshire branch

An online talk on early phase drug development from a non-clinical setting to use in humans


The process to obtain regulatory approval for a new drug has several phases, irrespective of whether the drug is a new chemical or biological entity, a new formulation, or a generic "me-too” drug.

This lecture, delivered by Viktoria McDonald, director and owner of AlbaTox Consulting Ltd., will provide an introduction to the two early phases of preclinical and first-in-human trials.

The talk will last for 45 minutes, and will be followed by time for questions from the audience.

Cost and booking

This event is free to attend and open to all. Advance registration is essential and the Zoom link will be circulated to registered attendees in advance.

Contact

For specific event queries, please contact Chris Collins at ccollins@qscl.co.uk
For booking or website queries, contact Harriet McAra at regions@rsb.org.uk or on 020 3925 3445.

Continuing Professional Development (CPD)

This event has been approved by the Royal Society of Biology for the purposes of CPD and can be counted as 3 CPD points.